GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹256 Cr | ₹230 Cr | ₹132 Cr | ₹68 Cr | ₹59 Cr |
What is the latest Total Liabilities ratio of GENNEX LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹256 Cr |
| Mar2024 | ₹230 Cr |
| Mar2023 | ₹132 Cr |
| Mar2022 | ₹68 Cr |
| Mar2021 | ₹59 Cr |
How is Total Liabilities of GENNEX LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹256 Cr | 11.36 | |
| Mar2024 | ₹230 Cr | 73.82 | |
| Mar2023 | ₹132 Cr | 94.30 | |
| Mar2022 | ₹68 Cr | 15.49 | |
| Mar2021 | ₹59 Cr | - | |
Compare Total Liabilities of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹333.5 Cr | -4.8% | -3.3% | -28.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹425,102.0 Cr | 1.2% | 5.5% | 0.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,299.0 Cr | -1.8% | -3.1% | 8.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹126,753.0 Cr | -2% | 2.8% | 19.2% | Stock Analytics | |
| CIPLA | ₹121,735.0 Cr | -0.7% | -8.6% | 2.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,155.0 Cr | -1.5% | -4.3% | 2.5% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -4.8% |
-3.3% |
-28.6% |
| SENSEX | -0.1% |
0% |
9% |
You may also like the below Video Courses